English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background The extended spectrum s-lactamases (ESBL) are enzymes that produce resistance to s-lactam antibiotics, including penicillins, wide spectrum cephalosporins and aztreonam, by cleavage of s-lactam ring (BUSH & JACOBY, 2010). Since ESBL-producing bacteria are frequently associated with nosocomial infections, treatment options are becoming increasingly limited (RAWAT & NAIR, 2010). In this context, the discovery of compounds which can inhibit the growth of micro-organisms which produce these enzymes becomes increasingly important.

Antimicrobial activity of the trans-cinnamaldehyde on nosocomial enteric bacilli producers of extended spectrum β-lactamase (ESBL)